FINAL LIVE WEBINAR OF 2026 AND 6 BUYs FOR YOU
Early Bird tickets: $29.95
We provide serious investors with specific BUY/SELL/HOLD advice on undervalued micro, small, and mid-cap growth and value stocks. We dig deeper and search further into areas where traditional big bank or large institutional research will not look, providing you with independent first coverage of the fastest growing small-cap stocks.
KeyStone’s Income/Growth Stock Research Service provides retail and professional investors with independent BUY/SELL advice on Canada’s top Dividend Growth Stocks. By subscribing to KeyStone’s Income/Growth Stock Research Service you can start building your income/growth producing portfolio immediately, or re-tool a portfolio you already have.
Our USGS Research is designed to help you prudently and systematically build and develop your growth stock portfolio over a 6-month to 3-year period and help you beat the market long term. We believe in a patient approach that involves time-tested fundamental research in the under-researched area of the market – Small-Cap Growth & Value stocks.
We provide serious investors with specific BUY/SELL/HOLD advice from a universe of ~8,000 stocks, focussed on under-followed, profitable, growth-oriented U.S. small-caps. No stone is left unturned to uncover 8-15 profitable, undervalued U.S. small caps, a select few with 10x potential.
Includes all 5 of KeyStone’s Research Services, Canadian Small-Cap Growth Stock Research (SCR), Canadian Income/Dividend Stock Research (ISR), U.S. Dividend & Large-Cap Growth Research (USR), U.S. Small-Cap Growth Stock Research (USSC), Simple TFSA Portfolio (TFSA), Exclusive VIP Bonus: 2 Semi-Annual VIP Webcasts ($500), Over 100 Analyst Hosted Weekly Q&A Chat Sessions, All Special Reports (Priced at $599 individually), Best Savings ($1,500 off regular price of $4,995).
In the world of stock markets dominated by large banks and investment companies, KeyStone’s independent Research Services offer a unique and completely independent perspective designed to help savvy investors make informed portfolio decisions.
Growth-Oriented Gold Miller Posts Sequentially Better But Year-Over-Year Weaker Q3, Execution on Expansion Solid, Tax Risk Heightened Near Term, Discount to Fair Value – Expect Volatility: Maintain Long-Term SPEC BUY
Record Quarterly Performance, Accelerating Revenue Growth And Strong Earnings Momentum Support A Positive Long-Term Outlook, Although Credit Quality And Funding Remain Key Areas To Monitor
Unique Health Care Service Firm Posts Decent Q2, Strong Free Cash Flow, Stock up 43% in Past Year, Shift Rating to HOLD